Alimentary Pharmacology & Therapeutics

Meta-analysis: mortality in Crohn's disease
pp. 861-870(10)
Authors: CANAVAN, C.; ABRAMS, K. R.; MAYBERRY, J. F.

Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children
pp. 871-881(11)
Authors: SZAJEWSKA, H.; SKÓRKA, A.; RUSZCZYŃSKI, M.; GIERUSZCZAK-BIAŁEK, D.

GI Epidemiology: nonalcoholic fatty liver disease
pp. 883-889(7)
Author: ANGULO, P.

Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B
pp. 891-898(8)
Authors: CHAN, H. L.-Y.; WONG, V. W.-S.; TSE, C.-H.; CHIM, A. M.-L.; CHAN, H.-Y.; WONG, G. L.-H.; SUNG, J. J.-Y.

Treatment of chronic he1patitis C genotype 1 with peginterferon- α2a (40 kDa) plus ribavirin under routine clinical practice in Spain: early prediction of sustained virological response rate
pp. 899-906(8)
Authors: DIAGO, M.; OLVEIRA, A.; SOLÁ, R.; ROMERO-GÓMEZ, M.; MORENO-OTERO, R.; PÉREZ, R.; SALMERÓN, J.; ENRÍQUEZ, J.; PLANAS, R.; GAVILÁN, J. C.; DEL OLMO, J.; URIBARRENA, R.; SILLERO, C.; BENÍTEZ, A.; SÁNCHEZ-GALDÓN, S.; DALMAU, B.; ERAÑA, L.; MONTORO, M.; PORTU, J.; GARIJO, J. M.; BARNIOL, R.; DOMÍNGUEZ, A.; ROTA, R.; OLCOZ, J. L.; ANTÓN, M.; PAMPLONA, X.; CASANOVAS, T.; JIMÉNEZ, E.; HUARTE, M.; DÍAZ, F.; SÁNCHEZ-RUANO, J.; ORIVE, M.; MUÑOZ-SÁNCHEZ, M.; ROSET, M.

Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer
pp. 907-912(6)
Authors: CHRISTENSEN, S.; RIIS, A.; NØRGAARD, M.; THOMSEN, R. W.; SØRENSEN, H. T.

Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident
pp. 913-924(12)
Authors: ABRAHAM, N. S.; EL-SERAG, H. B.; HARTMAN, C.; RICHARDSON, P.; DESWAL, A.

Early changes in rectal nitric oxide and mucosal inflammatory mediators in Crohn's colitis in response to infliximab treatment
pp. 925-932(8)
Authors: LJUNG, T.; AXELSSON, L.-G.; HERULF, M.; LUNDBERG, J. O.; HELLSTRÖM, P. M.

Altered intestinal permeability is predictive of early relapse in children with steroid-responsive ulcerative colitis
pp. 933-939(7)
Authors: MIELE, E.; PASCARELLA, F.; QUAGLIETTA, L.; GIANNETTI, E.; GRECO, L.; TRONCONE, R.; STAIANO, A.

Thiopurine metabolite monitoring in paediatric inflammatory bowel disease
pp. 941-947(7)
Authors: OOI, C. Y.; BOHANE, T. D.; LEE, D.; NAIDOO, D; DAY, A. S

Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study
pp. 949-954(6)
Authors: SIMON-RUDLER, M.; MASSARD, J.; BERNARD-CHABERT, B.; DI MARTINO, V.; RATZIU, V.; POYNARD, T.; THABUT, D.

Double stenting of oesophagus and airways in palliative treatment of patients with oesophageal cancer is efficient but associated with a high morbidity
pp. 955-963(9)
Authors: LECLEIRE, S.; ANTONIETTI, M.; DI FIORE, F.; BEN-SOUSSAN, E.; BOTA, S.; HELLOT, M.-F.; THIBERVILLE, L.; MICHEL, P.; LEREBOURS, E.; DUCROTTÉ, P.

Air swallowing, belching, acid and non-acid reflux in patients with functional dyspepsia
pp. 965-971(7)
Authors: CONCHILLO, J. M.; SELIMAH, M.; BREDENOORD, A. J.; SAMSOM, M.; SMOUT, A. J. P. M.

Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy?
pp. 973-986(14)
Authors: HAAG, S.; SENF, W.; TAGAY, S.; LANGKAFEL, M.; BRAUN-LANG, U.; PIETSCH, A.; HEUFT, G.; TALLEY, N. J.; HOLTMANN, G.

Prospective randomized trial evaluating ketamine for advanced endoscopic procedures in difficult to sedate patients
pp. 987-997(11)
Authors: VARADARAJULU, S.; ELOUBEIDI, M. A.; TAMHANE, A.; WILCOX, C. M.

Rebound acid hypersecretion
pp. 999-1000(2)
Authors: Fossmark, R.; Waldum, H.

Rebound acid hypersecretion: author's reply
pp. 1000-1000(1)
Authors: Hunfeld, N. G. M.; Geus, W. P.; Kuipers, E. J.

Errata / Corrigenda
pp. 1001-1002(2)

Errata / Corrigenda
pp. 1002-1002(1)

Errata / Corrigenda
pp. 1002-1002(1)

Errata / Corrigenda
pp. 1002-1002(1)